Skip to main content
. 2023 Sep 13;23:660. doi: 10.1186/s12884-023-05970-2

Table 2.

Primary and Secondary Outcomes of Allylestrenol versus Dydrogesterone after PSM

Variables Dydrogesterone (N = 989) Allylestrenol (N = 989) P-value
ART outcomes (%)
 Clinical pregnancy 526 (53.2) 529 (53.5) 0.928
 Non-pregnancy 346 (35.0) 397 (40.1) 0.020*
 Biochemical pregnancy 117 (11.8) 63 (6.4) < 0.001*
Pregnancy outcomes (%)
 Live birth 422 (42.67) 416 (42.06) 0.820
 Abortion 34 (3.44) 36 (3.64) 0.903
 Embryonic demise 55 (5.56) 59 (5.97) 0.772
 Labor induction 15 (1.52) 18 (1.82) 0.725
Ectopic pregnancy (%) 5 (0.5) 9 (0.9) 0.284
Multiple gestations (%) 111 (26.3) 70 (16.8) 0.001*

ART assisted reproductive techniques, PSM propensity score matching

*P < 0.05